Clinical Trials Directory

Trials / Completed

CompletedNCT05447897

Designing an Implementation Strategy for Lung Screening and Smoking Cessation Treatment in Community Health Centers

A Systematic Approach to Designing an Implementation Strategy to Increase Lung Cancer Screening and Smoking Cessation Treatment Among Federally Qualified Community Health Center Patients Who Smoke

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
9 (actual)
Sponsor
University of Colorado, Denver · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Accepted

Summary

Tobacco use is the leading preventable cause of death in the US and a major driver of health disparities. Among our tools for reducing the harms of tobacco is lung cancer screening (LCS). This study will combine a review of existing qualitative and quantitative data on barriers to lung cancer screening and smoking cessation in underserved populations, a quantitative analysis of predictors of lung cancer screening and smoking cessation treatment use among Massachusetts Federally Qualified Health Centers (FQHC)s, and a stakeholder advisory group to synthesize these data and select implementation strategies that reflects the critical determinants and the strengths and resource constraints of the Federally Qualified Health Centers (FQHC) context.

Detailed description

Aim 1) To design an implementation strategy that targets critical components in the delivery of SCT or LCS services for patients who smoke. Aim 2) To assess the acceptability, appropriateness and feasibility of the implementation strategy among community health center staff.

Conditions

Interventions

TypeNameDescription
OTHERQualitative Group InterviewsOne time interview, 60-90 minutes
OTHERStakeholder advisory groupThe team will meet with the stakeholder advisory group four times for 1-2 hours each

Timeline

Start date
2022-12-01
Primary completion
2023-05-31
Completion
2023-05-31
First posted
2022-07-07
Last updated
2024-04-16
Results posted
2024-04-16

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05447897. Inclusion in this directory is not an endorsement.